ATCO develops, formulates and manufactures its wide range of finished pharmaceuticals on its STATE-OF-ART, cGMP compliant facility housed in a double-story building, encompassing an area of 50,000 square feet, In addition to this ATCO has expanded its manufacturing facility and build another STATE OF ART fully cGMP compliant extension unit five story building on an area of 144,000 square feet, which fully meets the regulatory requirements of strict regulatory bodies like USFDA, MHRA, EU, PIC/S etc.

Since ATCO manufactures both sterile and non-sterile products, the plant is segregated into two units for manufacturing purposes. Sterile products include injections, ophthalmic drops and ointments, while non-sterile products include Tablets, Capsules, Dry-powder, Topical Ointments, Creams, Lotions and Oral Liquids.

There is a continuous production of a wide range of medicines through accurate processes and optimum use of resources to give the best quality. Proper controls are set in to ensure consistency of multiple batches and overall quality. Each and every process is validated for optimum performance. Highly qualified and skilled personnel are employed throughout the company.